← All indications

Rhabdomyosarcoma

A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)

Subtype terms (2)

More specific conditions that are subtypes of Rhabdomyosarcoma in the MeSH hierarchy.

Drugs by status

Organizations

Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 3 Indications (22)

Organization Involved with Other Experimental Indications (2)